Surgical Treatment of Hydrocephalus

Czech version

Authors: Dr. Mu Václav Vybíhal, Ph.D.
Authors‘ workplace: LF MU a FN Brno ; Neurochirurgická klinika
Published in: Cesk Slov Neurol N 2014; 77/110(1): 7-22
Category: Minimonography

Overview

Hydrocephalus is a disease developing as a result of failure in production, circulation or resorption of the cerebrospinal fluid. It develops due to congenital or acquired causes, including bleeding, inflammation, injury or tumour. Clinical symptoms depend on age, type and speed of development of hydrocephalus. Computed tomography, magnetic resonance and ultrasound in children with open anterior fontanel are used to diagnose hydrocephalus. Surgical therapy is a gold standard for the treatment of hydrocephalus. Shunt surgeries are performed more frequently than other types of surgical interventions. Ventriculoperitoneal shunts are preferred due to less serious complications that are easy to repair. Ventriculoatrial shunts are implanted when it is not possible to drain cerebrospinal fluid into the abdominal cavity. The need for multiple surgical revisions makes shunt surgery difficult. Endoscopic operations have a low complication rate and do not require implantation of a foreign material. However, endoscopic operations are not suitable in all types of hydrocephalus. They are mainly indicated in obstructive hydrocephalus, although they can also be used in some types of communicating hydrocephalus. In these instances, however, success rate is lower.

Key words:
hydrocephalus – shunt – ventriculoperitoneal shunt – ventriculoatrial shunt – lumboperitoneal shunt – endoscopy – endoscopic third ventriculostomy

The author declares he has no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Sources

1. Drake JM, Sainte‑ Rose C. History of cerebrospinal fluid shunts. In: Drake JM, Sainte‑ Rose C (eds). The shunt book. Cambridge: Blackwell Science 1995: 3– 12.

2. Hirsch JF. Surgery of hydrocephalus: past, present and future. Acta Neurochir (Wien) 1992; 116(2– 4): 155– 160.

3. Lifshutz JI, Johnson WD. History of hydrocephalus and its treatments. Neurosurg Focus 2001; 11(2): E1.

4. Grotenhuis JA. Manual of endoscopic procedures in neurosurgery. Nijmegen: Machaon 1995.

5. Dandy WE. Extirpation of the choroid plexus of the lateral ventricles in communicating hydrocephalus. Ann Surg 1918; 68(6): 569– 579.

6. Oi S. Hydrocephalus research update‑ controversies in definition and classification of hydrocephalus. Neurol Med Chir (Tokyo) 2010; 50(9): 859– 869.

7. Oi S, Sato O, Matsumoto S. A new classification for congenital hydrocephalus: prospective classification of congenital hydrocephalus (PCCH) and postnatal prognosis. Part 1. A proposal of a new classification of fetal/ neonatal/ infantile hydrocephalus based on neuronal maturation proces and chronological changes. No Shinkei Geka Journal 1994; 26(3): 122– 127.

8. Oi S, Honda Y, Hidaka M, Sato O, Matsumoto S. Intrauterina high‑resolution magnetic resonance imaging in fetal hydrocephalus and prenatal estimation of postnatal outcomes with „perspective classification“. J Neurosurg 1998; 88(4): 685– 694.

9. Oi S, Di Rocco C. Proposal of „evolution theory in cerebrospinal fluid dynamics“ and minor pathway hydrocephalus in developing immature brain. Childs Nerv Syst 2006; 22(7): 662– 669.

10. Oi S. Hydrocephalus chronology in adults: confused state of the terminology. Crit Rev Neurosurg 1998; 8(6): 346– 356.

11. Oi S, Matsumoto S. Patophysiology of nonneoplastic obstruction of the foramen of Monro and progressive unilateral hydrocephalus. Neurosurgery 1985; 17(6): 891– 896.

12. Oi S, Matsumoto S. Slit ventricles as a cause of isolated ventricles after shunting. Childs Nerv Syst 1985; 1(4): 189– 198.

13. Oi S, Matsumoto S. Isolated fourth ventricle. J Pediat Neurosci 1986; 2: 125– 133.

14. Oi S, Kudo H, Yamada H, Kim S, Hamano S, Urui S et al. Hydromeylic hydrocephalus. Correlation of hydromyelia with variouos stages of hydrocephlaus in postshunt isolated compartments. J Neurosurg 1991; 74(3): 371– 379.

15. Rekate HL. A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics. Childs Nerv Syst 2011; 27(10): 1535– 1541.

16. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal‑ pressure hydrocephalus. Neurosurgery 2005; 57 (Suppl 3): S4– S16.

17. Lipina R, Paleček T. Chirurgické řešení hydrocefalu v dětském věku. Pediatr Pro Prax 2004; 3: 133– 136.

18. Ng SES, Low AMS, Tang KK, Chan YH, Kwok RK. Value of quantitative MRI biomarkers (Evans’ index, aqueductal flow rate, and apparent diffusion coefficient) in idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 2009; 30(4): 708– 715.

19. Parkkola RK, Komu ME, Kotilainen EM, Valtonen SO,Thomsen C, Gideon P. Cerebrospinal fluid flow in patients with dilated ventricles studied with MR imaging. Eur Radiol 2000; 10(9): 1442– 1446.

20. Evans WA jr. An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatry 1942; 47(6): 931– 937.

21. Bartynski WS, Valliappan S, Uselman JH, Spearman MP. The adult radiographic shuntogram. AJNR Am J Neuroradiol 2000; 21(4): 721– 726.

22. Marmarou A, Foda MA, Bandoh K, Yoshihara M, Yamamoto T, Tsuji O et al. Posttraumatic ventriculomegaly: hydrocephalus or atrophy? A new approach for diagnosis using CSF dynamics. J Neurosurg 1996; 85(6): 1026– 1035.

23. Marmarou A, Bergsneider M, Klinge P, Relkin N,Black PM. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal‑ pressure hydrocephalus. Neurosurgery 2005; 57 (Suppl 3): S17– S28.

24. Haan J, Thomeer RT. Predictive value of temporary external lumbar drainage in normal pressure hydrocephalus. Neurosurgery 1988; 22(2): 388– 391.

25. Tisell M, Tullberg M, Hellström P, Edsbagge M, Högfeldt M, Wikkelsö C. Shunt surgery in patients with hydrocephalus and white matter changes. J Neurosurg 2011; 114(5): 1432– 1438.

26. Czosnyka M, Czosnyka ZH, Whitfield PC, Donovan T, Pickard JD. Age dependence of cerebrospinal pressure‑volume compensation in patients with hydrocephalus. J Neurosurg 2001; 94(3): 482– 486.

27. Marmarou A, Shulman K, Rosende RM. A nonlinear analysis of the cerebrospinal fluid system and intracranial pressure dynamics. J Neurosurg 1978; 48(3): 332– 344.

28. Katzman R, Hussey F. A simple constant‑ infusion manometric test for measurement of CSF absorption. Part I. Rationale nad Method. Neurology 1970; 20(6): 534– 544.

29. International PHVD Drug Trial Group. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. Lancet 1998; 352(9126): 433– 440.

30. Bhagwati SN, George K. Use of intrathecal hyaluronidase in the management of tuberculous meningitis with hydrocephalus. Childs Nerv Syst 1986; 2(1): 20– 25.

31. Morota N, Ihara S, Araki T. Torkildsen shunt: re‑evaluation of the historical procedure. Childs Nerv Syst 2010; 26(12): 1705– 1710.

32. Bret J. Recanalization of Sylvian aqueduct. Eur J Radiol 1981; 1(1): 67– 70.

33. Ramamurthi R, Sridhar K, Vasudevan MC. Textbook of operative neurosurgery. New Delhi: BI Publications Pvt Ltd 2005.

34. Ormond DR, Dressler A, Kim S, Ronecker J, Murali R.Lumbar drains may reduce the need for permanent CSF diversion in spontaneous subarachnoid haemorrhage. Br J Neurosurg 2013; 27(2): 171– 174.

35. Yu B, Li S, Lin Z, Zhang N. Treatment of posthemorrhagic hydrocephalus in premature infants with subcutaneous reservoir drainage. Pediatr Neurosurg 2009; 45(2): 119– 125.

36. Willis B, Javalkar V, Vannemreddy P, Caldito G, Matsuyama J, Guthikonda B et al. Ventricular reservoirs and ventriculoperitoneal shunts for premature infants with posthemorrhagic hydrocephalus: an institutional experience. J Neurosurg Pediatr 2009; 3(2): 94– 100.

37. Köksal V, Öktem S. Ventriculosubgaleal shunt procedure and its long‑term outcomes in premature infants with post‑hemorrhagic hydrocephalus. Childs Nerv Syst 2010; 26(11): 1505– 1515.

38. Schroeder HW, Oertel J, Gaab MR. Endoscopic treatment of cerebrospinal fluid pathway obstructions. Neurosurgery 2007; 60 (2 Suppl 1): ONS44– ONS51.

39. Novák Z, Kosorin K. Význam endoskopické septostomie. Cesk Slov Neurol N 2004; 67/ 100(2): 120– 123.

40. Warf BC. Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infants younger than 1 year of age: a prospective study in 550 African children. J Neurosurg 2005; 103 (Suppl 6): 475– 481.

41. Brockmeyer D, Abtin K, Carey L, Walker LM. Endoscopic third ventriculostomy: an outcome analysis. Pediatr Neurosurg 1998; 28(5): 236– 240.

42. Gangemi M, Donati P, Maiuri F, Longatti P, Godano U, Mascari C. Endoscopic third ventriculostomy for hydrocephalus. Minim Invas Neurosurg 1999; 42(3): 128– 132.

43. Rezaee O, Sharifi G, Samadian M, Haddadian K, Ali‑ Asgari A, Yazdani M. Endoscopic third ventriculostomy for treatment of obstructive hydrocephalus. Arch Iran Med 2007; 10(4): 498– 503.

44. Lipina R, Reguli S, Doležilová V, Kunčíková M, Podešvová H. Endoscopic third ventriculostomy for obstructive hydrocephalus in children younger than 6 months of age: is it a first‑ choice method? Childs Nerv Syst 2008; 24(9): 1021– 1027.

45. Kulkarni AV, Riva‑ Cambrin J, Browd SR. Use of the ETV Success Score to explain the variation in reported endoscopic third ventriculostomy success rates among published case series of childhood hydrocephalus. J Neurosurg Pediatr 2011; 7(2): 143– 146.

46. Siomin V, Cinalli G, Grotenhuis A, Golash A, Oi S, Kothbauer K et al. Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/ or hemorrhage. J Neurosurg 2002; 97(3): 519– 524.

47. Gangemi M, Maiuri F, Naddeo M, Godano U, Mascari C, Broggi G et al. Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus: an Italian multicenter study. Neurosurgery 2008; 63(1): 62– 67.

48. Pinto FC, Saad F, Oliveira MF, Pereira RM, Miranda FL,Tornai JB et al. Role of endoscopic third ventriculostomy and ventriculoperitoneal shunt in idiopathic normal pressure hydrocephalus: preliminary results of a randomized clinical trial. Neurosurgery 2013; 72(5): 845– 853.

49. Chan AK, McGovern RA, Zacharia BE, Mikell CB, Bruce SS, Sheehy JP et al. Inferior short‑ term safety profile of endoscopic third ventriculostomy as compared to ventriculoperitoneal shunt placement for idiopathic normal pressure hydrocephalus: a population‑ based study. Neurosurgery 2013; 73(6): 951– 961.

50. Mahapatra A, Mehr S, Singh D, Tandon M, Ganjoo P, Singh H. Ostomy closure and the role of repeat endoscopic third ventriculostomy (re‑ETV) in failed ETV procedures. Neurol India 2011; 59(6): 867– 873.

51. Hellwig D, Giordano M, Kappus C. Redo third ventriculostomy. World Neurosurg 2013; 79 (Suppl 2): S22.

52. Bouras T, Sgouros S. Complications of endoscopic third ventriculostomy: a systematic review. Acta Neurochir Suppl 2012; 113: 149– 153.

53. Navarro R, Gil‑ Parra R, Reitman AJ, Olavarria G, Grant JA, Tomita T. Endoscopic third ventriculostomy in children: early and late complications and their avoidance. Childs Nerv Syst 2006; 22(5): 506– 513.

54. Dusick JR, McArthur DL, Bergsneider M. Success and complication rates of endoscopic third ventriculostomy for adult hydrocephalus: a series of 108 patients. Surg Neurol 2008; 69(1): 5– 15.

55. Gangemi M, Maiuri F, Buonamassa S, Colella G,de Divitiis E. Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus. Neurosurgery 2004; 55(1): 129– 134.

56. Grunert P, Charalampaki P, Hopf N, Filippi R. The role of third ventriculostomy in the management of obstructive hydrocephalus. Minim Invasive Neurosurg 2003; 46(1): 16– 21.

57. Hader WJ, Walker RL, Myles ST, Hamilton M. Complications of endoscopic third ventriculostomy in previously shunted patients. Neurosurgery 2008; 63 (Suppl 1): ONS168– ONS175.

58. Aldana PR, Kestle JR, Brockmeyer DL, Walker ML.Results of endoscopic septal fenestration in the treatment of isolated ventricular hydrocephalus. Pediatr Neurosurg 2003; 38(6): 286– 294.

59. Hamada H, Hayashi N, Kurimoto M, Umemura K, Hirashima Y, Endo S. Neuroendoscopic septostomy for isolated lateral ventricle. Neurol Med Chir (Tokyo) 2003; 43(12): 582– 587.

60. Oertel JM, Schroeder HW, Gaab MR. Endoscopic stomy of the septum pellucidum: indications, technique, and results. Neurosurgery 2009; 64(3): 482– 491.

61. Tamburrini G, Frassanito P, Massimi L, Caldarelli M, Di Rocco C. Endoscopic septostomy through a standard precoronal ventricular access: feasibility and effectiveness. Acta Neurochir (Wien) 2012; 154(8): 1517– 1522.

62. Manwaring KH, Fritsch MJ. Endoscopic aqueductal stenting as an option for obstructive hydrocephalus. Neurosurgery 1998; 43(3): 712– 713.

63. Teo C, Burson T, Misra S. Endoscopic treatment of the trapped fourth ventricle. Neurosurgery 1999; 44(6): 1257– 1261.

64. Schroeder HW, Gaab MR. Endoscopic aqueductoplasty: technique and results. Neurosurgery 1999; 45(3): 508– 515.

65. Oertel JM, Vulcu S, Schroeder HW, Konerding MA,Wagner W, Gaab MR. Endoscopic transventricular third ventriculostomy through the lamina terminalis. J Neurosurg 2010; 113(6): 1261– 1269.

66. Rangel‑ Castilla L, Hwang SW, Jea A, Torres‑ Corzo J.Efficacy and safety of endoscopic transventricular lamina terminalis fenestration for hydrocephalus. Neurosurgery 2012; 71(2): 464– 473.

67. Oi S, Hidaka M, Honda Y, Togo K, Shinoda M, Shimoda M et al. Neuroendoscopic surgery for specific forms of hydrocephalus. Childs Nerv Syst 1999; 15(1): 56– 68.

68. Kalhorn SP, Strom RG, Harter DH. Idiopathic bilateral stenosis of the foramina of Monro treated using endoscopic foraminoplasty and septostomy. Neurosurg Focus 2011; 30(4): E5.

69. Mohanty A, Das BS, Sastry Kolluri VR, Hedge T. Neuro‑endoscopic fenestration of occluded foramen of Monro causing unilateral hydrocephalus. Pediatr Neurosurg 1996; 25(5): 248– 251.

70. Krähenbühl AK, Baldauf J, Gaab MR, Schroeder HW.Endoscopic temporal ventriculocisternostomy: an option for the treatment of trapped temporal horns. Neurosurg Pediatr 2013; 11(5): 568– 574.

71. Kalousdian S, Karlan MS, Williams MA. Silicone elastomer cerebrospinal fluid shunt systems. Council on Scientific Affairs, American Medical Association. Neurosurgery 1998; 42(4): 887– 892.

72. Eymann R, Kim YJ, Bohle RM, Antes S, Schmitt M,Menger MD et al. Microstructural alterations of silicone catheters in an animal experiment: histopathology and SEM findings. Acta Neurochir Suppl 2012; 113: 87– 90.

73. Ellis MJ, Kazina CJ, Del Bigio MR, McDonald PJ. Treatment of recurrent ventriculoperitoneal shunt failure associated with persistent cerebrospinal fluid eosinophilia and latex allergy by use of an “extracted” shunt. J Neurosurg Pediatr 2008; 1(3): 237– 239.

74. Hashimoto M, Yokota A, Urasaki E, Tsujigami S, Shimono M. A case of abdominal CSF pseudocyst associated with silicone allergy. Childs Nerv Syst 2004; 20(10): 761– 764.

75. Hussain NS, Wang PP, James C, Carson BS, Avellino AM. Distal ventriculoperitoneal shunt failure caused by silicone allergy. Case report. J Neurosurg 2005; 102(3): 536– 539.

76. VandeVord PJ, Gupta N, Wilson RB, Vinuya RZ, Schaefer CJ, Canady AI et al. Immune reactions associated with silicone‑based ventriculo‑ peritoneal shunt malfunctions in children. Biomaterials 2004; 25(17): 3853– 3860.

77. Yamamoto S, Ohno K, Aoyagi M, Ichinose S, Hirakawa K. Calcific deposits on degraded shunt catheters: long‑term follow‑up of V‑ P shunts and late complications in three cases. Childs Nerv Syst 2002; 18(1– 2): 19– 25.

78. Sotelo J. The hydrokinetic parameters of shunts for hydrocephalus might be inadequate. Surg Neurol Int 2012; 3: 40.

79. Aschoff A, Biedermann D, Biedermann N, El Tayeh A, Ludwig J, Piotrowicz A. Intelligent design? Status and perspectives of hydrocephalus valves. Cerebrospinal Fluid Res 2006; 3 (Suppl 1): S58.

80. Lutz BR, Venkataraman P, Browd SR. New and improved ways to treat hydrocephalus: Pursuit of a smart shunt. Surg Neurol Int 2013; 4 (Suppl 1): S38– S50.

81. Zabramski JM, Preul MC, Debbins J, McCusker DJ. 3T magnetic resonance imaging testing of externally programmable shunt valves. Surg Neurol Int 2012; 3: 81.

82. Toma AK, Tarnaris A, Grieve JP, Watkins LD, Kitchen ND. Adjustable shunt valve‑induced magnetic resonance imaging artifact: a comparative study. J Neurosurg 2010; 113(1): 74– 78.

83. Matushita H, Cardeal D, Pinto FC, Plese JP, de Miranda JS. The ventriculoomental bursa shunt. Childs Nerv Syst 2008; 24(8): 949– 953.

84. Williams PL, Warwick R, Dyson M. The peritoneum. In: Williams PL, Dyson M (eds.) Gray’s anatomy. Churchill Livingstone 1989: 1336– 1347.

85. Tubbs RS, Wellons JC 3rd, Blount JP, Grabb PA, Oakes WJ. Referred shoulder pain from ventriculoperitoneal shunts. Report of three cases. J Neurosurg 2005; 102 (Suppl 2): 218– 220.

86. Roth J, Sagie B, Szold A, Elran H. Laparoscopic versus non‑laparoscopic‑ assisted ventriculoperitoneal shunt placement in adults. A retrospective analysis. Surg Neurol 2007; 68(2): 177– 184.

87. Neale ML, Falk GL. In vitro assessment of back pressure on ventriculoperitoneal shunt valves. Is laparoscopy safe? Surg Endosc 1999; 13(5): 512– 515.

88. Kala M. Hydrocefalus. Praha: Galén 2005.

89. Kunc Z. Neurochirurgie. 3. vydání. Praha: Avicenum 1983.

90. Plas J et al. Neurochirurgie. Praha: Galén‑ Karolinum 2000.

91. Metellus P, Hsu W, Kharkar S, Kapoor S, Scott W, Rigamonti D. Accuracy of percutaneous placement of a ventriculoatrial shunt under ultrasonography guidance: a retrospective study at a single institution. J Neurosurg 2009; 110(5): 867– 870.

92. Meyer FB. Atlas of neurosurgery. Philadelphia: Churchill Livingstone 1999.

93. Momin EN, Recinos PF, Coon AL, Rigamonti D. Use of intraoperative venography to guide the distal portion of a ventriculoatrial shunt past an obstruction in the central veins: technical case report. Neurosurgery 2010; 66 (Suppl Operative 6): 370– 371.

94. Słowiński J, Stomal M, Skaba T, Pieniazek J, Mrówka R. Percutaneous ventriculoatrial shunt: experience with 179 cases. Neurol Neurochir Pol 2006; 40(3): 198– 202.

95. McLone Dg. Comment. Neurosurgery 1993; 32: 383.

96. Aoki N. Lumboperitoneal shunt: clinical applications, complications, and comparison with ventriculoperitoneal shunt. Neurosurgery 1990; 26(6): 998– 1003.

97. Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J jr et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998; 43(2): 294– 303.

98. Tuli S, Drake JM. Multiple shunt failures: an analysis of relevant features. Childs Nerv Syst 1999; 15(2– 3): 79.

99. Barnes NP, Jones SJ, Hayward RD, Harkness WJ, Thompson D. Ventriculoperitoneal shunt block: what are the best predictive clinical indicators? Arch Dis Child 2002; 87(3): 198– 201.

100. Garton HJ, Kestle JR, Drake JM. Predicting shunt failure on the basis of clinical symptoms and signs in children. J Neurosurg 2001; 94(2): 202– 210.

101. Kim TY, Brown L, Stewart GM. Test characteristics of parent’s visual analog scale score in predicting ventriculoperitoneal shunt malfunction in the pediatric emergency department. Pediatr Emerg Care 2007; 23(8): 549– 552.

102. Acakpo‑ Satchivi L, Shannon CN, Tubbs RS, Wellons JC 3rd, Blount JP, Iskandar BJ et al. Death in shunted hydrocephalic children: a follow up study. Childs Nerv Syst 2008; 24(2): 197– 201.

103. Iskandar BJ, Tubbs S, Mapstone TB, Grabb PA, Bartolucci AA, Oakes WJ. Death in shunted hydrocephalic children in the 1990s. Pediatr Neurosurg 1998; 28(4): 173 – 176.

104. Rekate HL. Comment. Neurosurgery 2001; 48(4): 770.

105. Brichtová E, Chlachula M, Hrbáč T, Lipina R. Endoscopic third ventriculostomy in previously shunted children. Minim Invasive Surg 2013; 2013:584567.

106. Neils DM, Wang H, Lin J. Endoscopic third ventriculostomy for shunt malfunction: What to do with the shunt? Surg Neurol Int 2013; 4: 3.

107. Whitfield PC, Guazzo EP, Pickard JD. Safe removal of retained ventricular catheters using intraluminal choroid plexus coagulation. Technical note. J Neurosurg 1995; 83(6): 1101– 1102.

108. Brydon HL, Hayward R, Harkness W, Bayston R. Does the cerebrospinal fluid protein concentration increase the risk of shunt complications? Br J Neurosurg 1996; 10(3): 267– 273.

109. Brydon HL, Bayston R, Hayward R, Harkness W. The effect of protein and blood cells on the flow‑ pressure characteristics of shunts. Neurosurgery 1996; 38(3): 498– 504.

110. Schubert F, Fijen BP, Krauss JK. Laparoscopically assisted peritoneal shunt insertion in hydrocephalus: a prospective controlled study. Surg Endosc 2005; 19(12): 1588– 1591.

111. Bryant MS, Bremer AM, Tepas JJ 3rd, Mollitt DL, Nquyen TQ, Talbert JL. Abdominal complications of ventriculoperitoneal shunts. Case reports and review of the literature. Am Surg 1988; 54(1): 50– 55.

112. Komolafe EO, Adeolu AA, Komolafe MA. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Case illustration and review. Pediatr Neurosurg 2008; 44(1): 36– 42.

113. Cozzens JW, Chandler JP. Increased risk of distal ventriculoperitoneal shunt obstruction associated with slit valves or distal slits in the peritoneal catheter. J Neurosurg 1997; 87(5): 682– 686.

114. Lazareff JA, Peacock W, Holly L, Ver Halen J, Wong A, Olmstead C. Multiple shunt failures : an analysis of relevant factors. Childs Nerv Syst 1998; 14(6): 271– 275.

115. Popa F, Grigorean VT, Onose G, Popescu M, Strambu V, Sandu AM. Laparoscopic treatment of abdominal complications following ventriculoperitoneal shunt. J Med Life 2009; 2(4): 426– 436.

116. Johnson MC, Maxwell MS. Delayed intrapleural migration of a ventriculoperitoneal shunt. Childs Nerv Syst 1995; 11(6): 348– 350.

117. Thipphavong S, Kellenberger CJ, Rutka JT, Manson DE. Hepatic and colonic perforation by an abandoned ventriculoperitoneal shunt. Pediatr Radiol 2004; 34(9): 750– 752.

118. Kim BJ, Cha SH, Park DJ, Song GS, Choi CH, Lee YW.A case of intracardiac migration of distal ventriculo‑ peritoneal (V‑ P) shunt catheter. J Korean Neurosurg Soc 2000; 29(2): 270– 273.

119. Selcuklu A, Pasaoglu A, Akdemir H, Kurtsoy A, Kavuncu I. Migration of the peritoneal catheter of a ventriculoperitoneal shunt into the scrotum. Case report. Turk Neurosurg 1991; 2(1): 52– 53.

120. Gupta SK, Jaiswal AK, Kumar S. Ventriculoperitoneal shunt catheter masquerading as ascariasis. J Clin Neurosci 2005; 12(8): 966– 967.

121. Bani A, Telker D, Hassler W, Grundlach M. Minimally invasive implantation of the peritoneal catheter in ventriculoperitoneal shunt placement for hyrocephalus: analysis of data in 151 consecutive adult patients. J Neurosurg 2006; 105(6): 869– 872.

122. Sridhar K, Karmarkar V. Peroral extrusion of ventriculoperitoneal shunt: case report and review of literature. Neurol India 2009; 57(3): 334– 336.

123. Yavuz C, Demırtas S, Calıskan A, Kamasak K, Karahan O, Guclu O et al. Reasons, procedures, and outcomes in ventriculoatrial shunts: A single‑center experience. Surg Neurol Int 2013; 4: 10.

124. Drucker MH, Vanek VW, Franco AA, Hanson M, Woods L. Thromboembolic complications of ventriculoatrial shunts. Surg Neurol 1984; 22(5): 444– 448.

125. Kluge S, Baumann HJ, Regelsberger J, Kehler U, Gliemroth J, Koziej B et al. Pulmonary hypertension after ventriculoatrial shunt implantation. J Neurosurg 2010; 113(6): 1279– 1283.

126. Haffner D, Schindera F, Aschoff A, Matthias S,Waldherr R, Schärer K. The clinical spectrum of shunt nephritis. Nephrol Dial Transplant 1997; 12(6): 1143– 1148.

127. Choux M. Commentary. Surg Neurol 1995; 43(4): 323.

128. Kajimoto Y, Ohta T, Miyake H, Matsukawa M, Ogawa D, Nagao K et al. Posture‑related changes in the pressure environment of the ventriculoperitoneal shunt system. J Neurosurg 2000; 93(4): 614– 617.

129. Lundkvist B, Eklund A, Kristensen B, Fagerlund M,Koskinen LO, Malm J. Cerebrospinal fluid hydrodynamics after placement of a shunt with an antisiphon device: a long‑term study. J Neurosurg 2001; 94(5): 750– 756.

130. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992; 77(6): 875– 880.

131. Korinek AM, Fulla‑ Oller L, Boch AL, Golmard JL,Hadiji B, Puybasset L. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8‑year study. Neurosurgery 2011; 68(4): 985– 994.

132. Kulkarni AV, Drake JM, Lamberti‑ Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001; 94(2): 195– 201.

133. Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD et al. Management of shunt infections: a multicenter pilot study. J Neurosurg 2006; 105 (Suppl 3): 177– 181.

134. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven‑year experience. Am J Dis Child 1984; 138(12): 1103– 1108.

135. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K,Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003; 36(7): 858– 862.

136. Tulipan N, Cleves MA. Effect of an intraoperative double‑gloving strategy on the incidence of cerebrospinal fluid shunt infection. J Neurosurg 2006; 104 (Suppl 1): 5– 8.

137. Overturf GD. Defining bacterial meningitis and other infections of the central nervous system. Pediatr Crit Care Med 2005; 6 (Suppl 3): S14– S18.

138. Parker SL, Attenello FJ, Sciubba DM, Garces‑ Ambrossi GL, Ahn E, Weingart J et al. Comparison of shunt infection incidence in high‑risk subgroups receiving antibiotic‑ impregnated versus standard shunts. Childs Nerv Syst 2009; 25(1): 77– 83.

139. Sciubba DM, Lin LM, Woodworth GF, McGirt MJ,Carson B, Jallo GI. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 2007; 22(4): E9.

140. Kan P, Kestle J. Lack of efficacy of antibiotic‑ impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 2007; 23(7): 773– 777.

141. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M,Will BE. Do antibiotic‑ impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007; 7(5): 38.